Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers

Lu Yang(Zhengzhou University), Junnan Tang(University of North Carolina at Chapel Hill)
Journal for ImmunoTherapy of Cancer
January 1, 2025
Cited by 14


Related Papers